MedImmune Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MedImmune

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Alexander Hardin who wrote (101)	3/11/1998 2:30:00 PM
From: bill small	of 416

Hi Alexander, Suggest you call MEDI investor relations chief, Mark Kaufmann, 301 417 0770 x321 and get an investor kit. Ask Mark to include analyst reports in the kit. I live near company and follow pretty closely. They have a significant pipeline but real story is company should begin profitability this year. Fast revenue/profit growth is projected as the drugs on market support continued development of pipeline. This is one of the best bets in the bioteck sector IMO. Also MEDI is an especially first class company based on my personal experiences with them. Take a look and then we can discuss further. best of luck.....Bill

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next